Literature DB >> 22019418

Lack of signaling by IL-4 or by IL-4/IL-13 has more attenuating effects on Leishmania amazonensis dorsal skin--than on footpad-infected mice.

Tania C Felizardo1, Maria I C Gaspar-Elsas, Gloria M C A Lima, Ises A Abrahamsohn.   

Abstract

Lesion development in tegumentary leishmaniasis is markedly influenced by the inoculation site and the type and number of injected infective forms. This and the yet unclear contribution of Th2 cytokines as susceptibility factors to Leishmania amazonensis infection prompted us to investigate the roles of IL-4, IL-13 and IL-10 on C57BL/6 and BALB/c mice infected in the footpad (paw) or rump with low-dose L. amazonensis purified-metacyclics. Wild-type (WT) mice of either strain developed, in the rump, a single large ulcerated lesion whereas paw lesions never ulcerated and were much smaller in C57BL/6 than in BALB/c mice. However, rump-inoculated IL-4-deficient (IL-4(-/-)) C57BL/6 mice did not develop any visible lesions although parasites remained in the dermis and lymph nodes, even after systemic IL-10-receptor blocking. By comparison, all IL-4(-/-) BALB/c mice developed rump ulcers. Strikingly, only 30% of rump-infected IL-4Rα(-/-) BALB/c mice developed lesions. IL-4(-/-) mice had higher IFN-γ and lower IL-10 and IL-13 levels than WT mice. Paw-infected IL-4Rα(-/-) BALB/c mice developed minimal paw lesions. While other factors contributing to L. amazonensis susceptibility cannot be discounted, our results indicate that absent signalling by IL-4 or by IL-4/IL-13 have more intense attenuating effects on rump than on paw lesions but do not eradicate parasitism.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22019418     DOI: 10.1016/j.exppara.2011.09.015

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  7 in total

1.  The role of the P2X7 receptor in murine cutaneous leishmaniasis: aspects of inflammation and parasite control.

Authors:  Vanessa Ribeiro Figliuolo; Suzana Passos Chaves; Luiz Eduardo Baggio Savio; Maria Luiza Prates Thorstenberg; Érika Machado Salles; Christina Maeda Takiya; Maria Regina D'Império-Lima; Herbert Leonel de Matos Guedes; Bartira Rossi-Bergmann; Robson Coutinho-Silva
Journal:  Purinergic Signal       Date:  2016-11-19       Impact factor: 3.765

2.  Exogenous IL-13 exacerbates Leishmania major infection and abrogates acquired immunity to re-infection.

Authors:  Muriel T Zaatar; Youssef Simaan; Marc C Karam
Journal:  Parasitol Res       Date:  2022-05-10       Impact factor: 2.289

3.  Leishmania braziliensis and Leishmania amazonensis amastigote extracts differ in their enhancement effect on Leishmania infection when injected intradermally.

Authors:  Cintia F de Araújo; Virgínia M G Silva; Andre Cronemberger-Andrade; Luciana S Aragão-França; Viviane C J Rocha; Priscila S L Santos; Lain Pontes-de-Carvalho
Journal:  BMC Res Notes       Date:  2014-02-01

4.  Impact of reactive oxygen species (ROS) on the control of parasite loads and inflammation in Leishmania amazonensis infection.

Authors:  Eric Henrique Roma; Juan Pereira Macedo; Grazielle Ribeiro Goes; Juliana Lauar Gonçalves; Waldionê de Castro; Daniel Cisalpino; Leda Quercia Vieira
Journal:  Parasit Vectors       Date:  2016-04-07       Impact factor: 3.876

5.  Dietary Vitamin D3 Deficiency Increases Resistance to Leishmania (Leishmania) amazonensis Infection in Mice.

Authors:  Izabella Pereira da Silva Bezerra; Gabriel Oliveira-Silva; Danielle Sophia Ferreira Santos Braga; Mirian França de Mello; Juliana Elena Silveira Pratti; Joyce Carvalho Pereira; Alessandra Marcia da Fonseca-Martins; Luan Firmino-Cruz; Diogo Maciel-Oliveira; Tadeu Diniz Ramos; André Macedo Vale; Daniel Claudio Oliveira Gomes; Bartira Rossi-Bergmann; Herbert Leonel de Matos Guedes
Journal:  Front Cell Infect Microbiol       Date:  2019-04-09       Impact factor: 5.293

6.  Characterization of Sv129 Mice as a Susceptible Model to Leishmania amazonensis.

Authors:  Júlio Souza Dos-Santos; Luan Firmino-Cruz; Tadeu Diniz Ramos; Alessandra Marcia da Fonseca-Martins; Diogo Oliveira-Maciel; Juliana Valente Rodrigues De-Medeiros; Suzana Passos Chaves; Daniel Claudio Oliveira Gomes; Herbert Leonel de Matos Guedes
Journal:  Front Med (Lausanne)       Date:  2019-05-29

7.  Immunotherapy using anti-PD-1 and anti-PD-L1 in Leishmania amazonensis-infected BALB/c mice reduce parasite load.

Authors:  Alessandra M da Fonseca-Martins; Tadeu D Ramos; Juliana E S Pratti; Luan Firmino-Cruz; Daniel Claudio Oliveira Gomes; Lynn Soong; Elvira M Saraiva; Herbert L de Matos Guedes
Journal:  Sci Rep       Date:  2019-12-30       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.